Pharmaceutical Promotion to Physicians and First Amendment Rights
16 april 2008
In mid-February, the Food and Drug Administration (FDA) proposed a change in its rules governing pharmaceutical promotion that would widen the ability of drug manufacturers to distribute information on unapproved uses of their products.1 This proposal has rekindled the debate over the rights of drug makers to promote their medications to physicians.
Bron: NEJM
| < Vorige | Volgende > |
|---|
